Dr. Marc Lee Melcher, MD, PhD

Dr. Melcher practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Melcher's NPI, 1003870486, was assigned on April 13, 2006. Dr. Melcher graduated from Vagelos College of Physicians and Surgeons in 1999. Dr. Melcher holds California license A73407.

Dr. Melcher's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Melcher's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Melcher is also affiliated with Lucile Packard Children's Hospital Stanford. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Melcher to 1 more hospital and 1 medical group, each named with a free account. Dr. Melcher's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Melcher practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Melcher's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Melcher is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Melcher's licenses on file in 2 states: California and Nevada.

Dmand AI lists kidney transplant among the conditions Dr. Melcher treats.

CMS data shows 217 Medicare services from Dr. Melcher across 4 procedure codes in 2024, for 94 Medicare patients. Medicare paid $48,827 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 94 Medicare patients who saw Dr. Melcher in 2024. The largest group is under 65, with 53 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 59% are also on Medicaid. Their average risk score is 7.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Melcher's median patient age at 51, with 39% women.

In 2024, Dr. Melcher wrote 777 Medicare Part D claims for 72 patients. 85% of them were for generic drugs. CMS names the drug for 613 of them, across 19 drugs with 11 or more claims each, at $29,055 in total drug cost. In 2023, CMS named 915 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Melcher for performance year 2024, reported as part of a group. Dr. Melcher accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 118 papers to Dr. Melcher, published from 2008 to 2025. 2023 was the busiest year, with 17. The most frequent topics are Liver Transplantation, Kidney Transplantation and Graft Survival. Dr. Melcher has published most often in Am J Transplant. Dr. Melcher's most frequent co-authors are Kazunari Sasaki, MD, Allison June Kwong, MD and Carlos Orlando Esquivel, MD, PhD.

Dmand AI links Dr. Melcher to 1 clinical trial. Conditions studied include Blood Loss, Surgical and Intraoperative Complications.

CMS Open Payments shows 20 general payments to Dr. Melcher from 5 drug and device companies from 2018 to 2025. Travel and lodging make up the largest share, 73% of the total. TransMedics, Inc. paid the most, $4,076.

Dmand AI lists 2 awards for Dr. Melcher, most recently CMS Stage 1 EHR in 2013.

Dr. Melcher graduated from Vagelos College of Physicians and Surgeons in 1999. Dr. Melcher is a member of AOA, ACS, American Society of Transplant Surgeons and AAS.

Dr. Melcher is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.